IBDEI1QQ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31152,2)
 ;;=^5009051
 ;;^UTILITY(U,$J,358.3,31153,0)
 ;;=L03.316^^190^1932^114
 ;;^UTILITY(U,$J,358.3,31153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31153,1,3,0)
 ;;=3^Cellulitis of Umbilicus
 ;;^UTILITY(U,$J,358.3,31153,1,4,0)
 ;;=4^L03.316
 ;;^UTILITY(U,$J,358.3,31153,2)
 ;;=^5009052
 ;;^UTILITY(U,$J,358.3,31154,0)
 ;;=L03.319^^190^1932^113
 ;;^UTILITY(U,$J,358.3,31154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31154,1,3,0)
 ;;=3^Cellulitis of Trunk,Unspec
 ;;^UTILITY(U,$J,358.3,31154,1,4,0)
 ;;=4^L03.319
 ;;^UTILITY(U,$J,358.3,31154,2)
 ;;=^5009054
 ;;^UTILITY(U,$J,358.3,31155,0)
 ;;=L03.321^^190^1932^13
 ;;^UTILITY(U,$J,358.3,31155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31155,1,3,0)
 ;;=3^Acute Lymphangitis of Abdominal Wall
 ;;^UTILITY(U,$J,358.3,31155,1,4,0)
 ;;=4^L03.321
 ;;^UTILITY(U,$J,358.3,31155,2)
 ;;=^5009055
 ;;^UTILITY(U,$J,358.3,31156,0)
 ;;=L03.322^^190^1932^14
 ;;^UTILITY(U,$J,358.3,31156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31156,1,3,0)
 ;;=3^Acute Lymphangitis of Back
 ;;^UTILITY(U,$J,358.3,31156,1,4,0)
 ;;=4^L03.322
 ;;^UTILITY(U,$J,358.3,31156,2)
 ;;=^5009056
 ;;^UTILITY(U,$J,358.3,31157,0)
 ;;=L03.323^^190^1932^15
 ;;^UTILITY(U,$J,358.3,31157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31157,1,3,0)
 ;;=3^Acute Lymphangitis of Chest Wall
 ;;^UTILITY(U,$J,358.3,31157,1,4,0)
 ;;=4^L03.323
 ;;^UTILITY(U,$J,358.3,31157,2)
 ;;=^5009057
 ;;^UTILITY(U,$J,358.3,31158,0)
 ;;=L03.324^^190^1932^17
 ;;^UTILITY(U,$J,358.3,31158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31158,1,3,0)
 ;;=3^Acute Lymphangitis of Groin
 ;;^UTILITY(U,$J,358.3,31158,1,4,0)
 ;;=4^L03.324
 ;;^UTILITY(U,$J,358.3,31158,2)
 ;;=^5009058
 ;;^UTILITY(U,$J,358.3,31159,0)
 ;;=L03.325^^190^1932^23
 ;;^UTILITY(U,$J,358.3,31159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31159,1,3,0)
 ;;=3^Acute Lymphangitis of Perineum
 ;;^UTILITY(U,$J,358.3,31159,1,4,0)
 ;;=4^L03.325
 ;;^UTILITY(U,$J,358.3,31159,2)
 ;;=^5009059
 ;;^UTILITY(U,$J,358.3,31160,0)
 ;;=L03.326^^190^1932^29
 ;;^UTILITY(U,$J,358.3,31160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31160,1,3,0)
 ;;=3^Acute Lymphangitis of Umbilicus
 ;;^UTILITY(U,$J,358.3,31160,1,4,0)
 ;;=4^L03.326
 ;;^UTILITY(U,$J,358.3,31160,2)
 ;;=^5009060
 ;;^UTILITY(U,$J,358.3,31161,0)
 ;;=L03.329^^190^1932^28
 ;;^UTILITY(U,$J,358.3,31161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31161,1,3,0)
 ;;=3^Acute Lymphangitis of Trunk,Unspec
 ;;^UTILITY(U,$J,358.3,31161,1,4,0)
 ;;=4^L03.329
 ;;^UTILITY(U,$J,358.3,31161,2)
 ;;=^5009062
 ;;^UTILITY(U,$J,358.3,31162,0)
 ;;=L08.9^^190^1932^168
 ;;^UTILITY(U,$J,358.3,31162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31162,1,3,0)
 ;;=3^Local Infection of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,31162,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,31162,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,31163,0)
 ;;=L11.0^^190^1932^9
 ;;^UTILITY(U,$J,358.3,31163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31163,1,3,0)
 ;;=3^Acquired Keratosis Follicularis
 ;;^UTILITY(U,$J,358.3,31163,1,4,0)
 ;;=4^L11.0
 ;;^UTILITY(U,$J,358.3,31163,2)
 ;;=^5009091
 ;;^UTILITY(U,$J,358.3,31164,0)
 ;;=L20.0^^190^1932^90
 ;;^UTILITY(U,$J,358.3,31164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31164,1,3,0)
 ;;=3^Besnier's Prurigo
 ;;^UTILITY(U,$J,358.3,31164,1,4,0)
 ;;=4^L20.0
 ;;^UTILITY(U,$J,358.3,31164,2)
 ;;=^5009107
 ;;^UTILITY(U,$J,358.3,31165,0)
 ;;=L20.81^^190^1932^87
 ;;^UTILITY(U,$J,358.3,31165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31165,1,3,0)
 ;;=3^Atopic Neurodermatitis
 ;;^UTILITY(U,$J,358.3,31165,1,4,0)
 ;;=4^L20.81
